A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension
Clinical trial NCT02102750 · COMPLETED
Trial details
- NCT number
- NCT02102750
- Sponsor
- Santen Oy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-05-29
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.